Richa Sharma, MD, MPH
Associate Professor of NeurologyDownloadHi-Res Photo
Cards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileContact Info
About
Copy Link
Titles
Associate Professor of Neurology
Biography
Dr.Richa Sharma is a vascular neurologist who specializes in prevention and treatment of ischemic and hemorrhagic strokes. She trained in neurology as a resident at Johns Hopkins Hospital and in vascular neurology at Massachusetts General Hospital as a fellow. She was also selected as the StrokeNet Research Fellow at the Massachusetts General Hospital. Her research interests revolve around applying novel computational techniques to identify the underlying causes of stroke in individual patients. She is also interested in cardioembolic sources of stroke.
Last Updated on November 19, 2024.
Appointments
Neurology
Associate Professor on TermPrimary
Other Departments & Organizations
- All Institutions
- Center for Brain & Mind Health
- Center for Neuroepidemiology and Clinical Neurological Research
- Janeway Society
- Neurology
- Vascular Neurology
- Yale Biomedical Imaging Institute
- Yale Medicine
- Yale New Haven Health System
Education & Training
- StrokeNet Research Fellowship
- Massachusetts General Hospital (2019)
- Vascular Neurology Fellowship
- Massachusetts General Hospital (2018)
- Neurology Residency
- Johns Hopkins Hospital (2017)
- Internship
- Johns Hopkins Hospital (2014)
- MD
- Duke University School of Medicine (2013)
- MPH
- Yale School of Public Health (2009)
- BA
- Cornell University, Neurobiology and Behavior; Economics (2007)
Research
Copy Link
Overview
Medical Research Interests
Ischemic Stroke; Treatment Adherence and Compliance
ORCID
0000-0003-0798-2353
Research at a Glance
Yale Co-Authors
Frequent collaborators of Richa Sharma's published research.
Publications Timeline
A big-picture view of Richa Sharma's research output by year.
Research Interests
Research topics Richa Sharma is interested in exploring.
Adam de Havenon, MD, MS
Kevin Sheth, MD, FAHA
Guido J. Falcone, ScD, MPH
Cyprien Rivier, MD, MSc
Lauren Hachmann Sansing, MD, MS, FAHA, FANA
Charles Matouk, MD
36Publications
278Citations
Ischemic Stroke
Publications
2025
Unraveling disparities in county‐level dementia diagnosis prevalence across the United States
de Havenon A, Littig L, Falcone G, Sharma R, Fesharaki A, Yaghi S, Calvario E, Rosand J, Sheth K, Anderson C. Unraveling disparities in county‐level dementia diagnosis prevalence across the United States. Alzheimer's & Dementia 2025, 21: e70954. PMID: 41404852, PMCID: PMC12709554, DOI: 10.1002/alz.70954.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsDiagnosis prevalenceDementia diagnosisFast foodFast food accessImpact of targeted interventionsHigher diabetes prevalenceUninsured rateCounty-level variablesCounty-level variationDementia casesDiabetes prevalenceUnited StatesSmoking ratesHigh-burden communitiesMedicare beneficiariesHigher diabetesPrevention strategiesDementiaLogistic regressionPrevalenceBackward selectionLarger householdsHousehold sizePredictorsCountyIntracranial Occlusion in Cryptogenic Stroke Is Not Predictive of Recurrent Ischemic Stroke: A Propensity‐Score Matched Analysis of the Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence Study
Smith M, Brorson J, Goicoechea E, Penckofer M, Eklund K, Stretz C, Lineback C, Khasiyev F, Kerrigan D, Lewis S, Ali H, Aboul‐Nour H, de Havenon A, Culbertson C, Melkumova E, Jillella D, Dumitrascu O, Parikh P, Doolittle C, Yahnke I, Sathya A, Brown S, Kang J, Bowman A, Shahrivari M, Elangovan C, Sehgal S, Sloane K, Alvi M, Krishnaiah B, Kam W, Kothari S, Abu Qdais A, Farooqui M, Nahab F, Quintela G, Sharma R, Thottempudi N, Nedelcu S, Herpich F, Glover P, Chahien D, Liebeskind D, Linares G, Daniel J, Al Kasab S, Singh E, D'Souza M, Gaudio E, Aziz Y, Yaghi S, Kala N, Sarkar M, Goldstein E, Chen L, Van Coevering R, Thon J, Stamm B, Thompson S, Siegler J. Intracranial Occlusion in Cryptogenic Stroke Is Not Predictive of Recurrent Ischemic Stroke: A Propensity‐Score Matched Analysis of the Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence Study. Journal Of The American Heart Association 2025, 14: e041500. PMID: 40996035, PMCID: PMC12684489, DOI: 10.1161/jaha.125.041500.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsRate of recurrent strokePrimary outcomeMulticenter retrospective cohortRecurrent strokeIntracranial occlusionRetrospective cohort of adultsCohort of adultsCox proportional hazards modelsRecurrent ischemic strokeVascular risk factorsHigh-risk sourceEmbolic strokePropensity score matchingIschemic strokeProportional hazards modelCerebral microvascular diseaseCryptogenic strokeRisk of recurrenceScore matchingPropensity-score matching analysisMatching AnalysisSources of embolismHazards modelRisk factorsStroke preventionAssociation of Polygenic Susceptibility to Hyperlipidemia With Cholesterol Control and Recurrent Stroke in Ischemic Stroke Survivors
Wu K, Huo S, Rivier C, Torres-Lopez V, Sharma R, de Havenon A, Worrall B, Sheth K, Falcone G. Association of Polygenic Susceptibility to Hyperlipidemia With Cholesterol Control and Recurrent Stroke in Ischemic Stroke Survivors. Neurology 2025, 105: e213966. PMID: 40825160, DOI: 10.1212/wnl.0000000000213966.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsIschemic stroke survivorsStroke survivorsAssociated with riskSusceptible to hyperlipidemiaHigh riskUK BiobankResistant hyperlipidemiaCholesterol controlUncontrolled hyperlipidemiaSurvivors of ischemic strokeHigher risk of recurrent vascular eventsPolygenic risk scoresRisk factor controlRisk of recurrent vascular eventsAdverse genetic profileLow-density lipoprotein cholesterolRisk of acute coronary eventsGenetic association studiesRecurrent strokeClinical trajectoryGenetic risk variantsRisk of recurrent strokeAcute ischemic stroke survivorsPolygenic profilePrecision medicine toolsOutcomes of Patients With Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation
Siegler J, Goicoechea E, Penckofer M, Eklund K, Yaghi S, Stretz C, Lineback C, Stamm B, Peter S, D'Souza M, Conyers F, Khasiyev F, Kerrigan D, Lewis S, Ali H, Aboul-Nour H, Sharma R, Nahab F, Glover P, Thompson S, Alshaer Q, Thottempudi N, de Havenon A, Culbertson C, Melkumova E, Chionatos R, Jillella D, Daniel J, Ro J, Frankel M, Dumitrascu O, Brown S, Parikh P, Doolittle C, Yahnke I, Sathya A, Kang J, Kirchhoffer K, Bowman A, Smith M, Brorson J, Asabere A, Shahrivari M, Elangovan C, Sheibani N, Krishnaiah B, Gaudio E, Sloane K, Rothstein A, Alvi M, Annam S, Amankwah C, Kam W, Abburi N, Farooqui M, Rojas-Soto D, Molaie A, Khezri N, Zubair A, Abbasi M, Van Coevering R, Chen L, Nedelcu S, Herpich F, Chahien D, Sehgal S, Liebeskind D, Linares G, Zha A, Sarkar M, Xi R, Nelson A, Abu Qdais A, Al Kasab S, Singh E, Patel V, Aziz Y, Mehndiratta P, DeMarco A, Sharrief A, Cucchiara B, Salehi Omran S, Nguyen T, Dubinski M, Ackerman J, Thon J. Outcomes of Patients With Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation. Neurology 2025, 105: e213876. PMID: 40609061, DOI: 10.1212/wnl.0000000000213876.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsInverse probability of treatment weightingPotential embolic sourcesBenefits of anticoagulationLeft ventricular injuryEmbolic sourceEmbolic strokeMajor bleedingAntiplatelet therapyVentricular injuryComposite outcomeMedian NIH Stroke Scale scoreCohort studyRecurrent strokePrimary outcomePatients treated with anticoagulantsRetrospective observational cohort studyIschemic strokeTreated with anticoagulationConsecutive adult patientsRisk of recurrenceOutcomes of patientsCox proportional hazards regressionInverse probabilityNIH Stroke Scale scoreProbability of treatment weightingAcute Ischemic Stroke Risk Following Cardiac Interventions in the United States From 2016 to 2021
Koo A, Zhou L, Hameed I, Rivier C, Clocchiatti-Tuozzo S, Kamel H, Falcone G, Ney J, Sharma R, Matouk C, Yaghi S, Sheth K, de Havenon A. Acute Ischemic Stroke Risk Following Cardiac Interventions in the United States From 2016 to 2021. Neurology 2025, 105: e213766. PMID: 40493873, PMCID: PMC12165311, DOI: 10.1212/wnl.0000000000213766.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsIntervention hospitalsSurvey weightsNon-Hispanic black ethnicityNIH Stroke ScaleStroke riskIschemic strokeFactors associated with ischemic strokeAssociated with female sexCardiac interventionsIschemic stroke riskIncidence of ischemic strokeVariables associated with riskRate of ischemic strokeNational Inpatient SampleHigh-risk populationDiagnosis-related groupsIntervention patientsCross-sectional cohortUnited StatesAcute ischemic stroke riskIn-Hospital DeathRisk of strokeSecondary analysisBlack ethnicityInpatient mortalityIntegrated Genomic, Proteomic, and Transcriptomic Profiling Support Cathepsin-B as a Drug Repurposing Target in Cerebral Small Vessel Disease (S2.001)
Rivier C, Huo S, Clocchiatti-Tuozzo S, Renedo D, Sharma R, Payabvash S, Rangaraju S, Dong X, Sheth K, Sansing L, Falcone G. Integrated Genomic, Proteomic, and Transcriptomic Profiling Support Cathepsin-B as a Drug Repurposing Target in Cerebral Small Vessel Disease (S2.001). Neurology 2025, 104 DOI: 10.1212/wnl.0000000000211788.Peer-Reviewed Original ResearchFactors Associated With Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection
Mandel D, Shu L, Chang C, Jack N, Guerrero C, Henninger N, Muppa J, Affan M, Lodhi O, Heldner M, Antonenko K, Seiffge D, Arnold M, Omran S, Crandall R, Lester E, Mena D, Arauz A, Nehme A, Boulanger M, Touzé E, Sousa J, Sargento-Freitas J, Barata V, Castro-Chaves P, Brito M, Khan M, Mallick D, Rothstein A, Khazaal O, Kaufman J, Engelter S, Traenka C, de Sousa D, Soares M, Rosa S, Zhou L, Gandhi P, Field T, Mancini S, Metanis I, Leker R, Pan K, Dantu V, Baumgartner K, Burton T, von Rennenberg R, Nolte C, Choi R, MacDonald J, Shahripour R, Guo X, Ghannam M, Almajali M, Samaniego E, Sanchez S, Rioux B, Zine-Eddine F, Poppe A, Fonseca A, Baptista M, Cruz D, Romoli M, De Marco G, Longoni M, Keser Z, Griffin K, Kuohn L, Frontera J, Amar J, Giles J, Zedde M, Pascarella R, Grisendi I, Nzwalo H, Liebeskind D, Molaie A, Cavalier A, Kam W, Mac Grory B, Al Kasab S, Anadani M, Kicielinski K, Eltatawy A, Chervak L, Rivas R, Aziz Y, Bakradze E, Tran T, Gisbert M, Requena M, Velez F, Garcia J, Muddasani V, de Havenon A, Vishnu V, Yaddanapudi S, Adams L, Browngoehl A, Ranasinghe T, Dunston R, Lynch Z, Penckofer M, Siegler J, Mayer S, Willey J, Zubair A, Cheng Y, Sharma R, Marto J, Ferreira V, Klein P, Nguyen T, Asad S, Sarwat Z, Balabhadra A, Patel S, Secchi T, Martins S, Mantovani G, Kim Y, Krishnaiah B, Elangovan C, Lingam S, Qureshi A, Fridman S, Alvarado-Bolanos A, Khasiyev F, Linares G, Mannino M, Terruso V, Vassilopoulou S, Tentolouris-Piperas V, Marino M, Wall V, Indraswari F, Jamal S, Liu S, Alvi M, Ali F, Sarvath M, Morsi R, Kass-Hout T, Shi F, Zhang J, Sokhi D, Said J, Mongare N, Simpkins A, Gomez R, Sen S, Ghani M, Elnazeir M, Xiao H, Kala N, Khan F, Stretz C, Mohammadzadeh N, Goldstein E, Furie K, Yaghi S. Factors Associated With Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection. Stroke 2025, 56: 1413-1421. PMID: 40143807, DOI: 10.1161/strokeaha.124.048215.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCervical artery dissectionCox regressionOcclusive dissectionIschemic strokeArtery dissectionAssociated with subsequent stroke riskDiagnosis of cervical artery dissectionFactors associated with increased riskAssociated with increased risk of ischemic strokeStroke riskTreated with anticoagulationAssociated with increased riskOptimal treatment strategyHistory of ischemic strokeRetrospective observational studyRisk of ischemic strokeBenefits of anticoagulationIschemic stroke riskFactors associated with stroke recurrenceHigh-risk individualsIdentified risk factorsPost Hoc AnalysisCAD subgroupAntiplatelet therapyInitial diagnosisSilent Myocardial Infarction and Risk of Stroke Recurrence: A Post Hoc Analysis of the IRIS Trial
Ridha M, Zhang C, McCullough S, Viscoli C, Sharma R, Kamel H, Merkler A. Silent Myocardial Infarction and Risk of Stroke Recurrence: A Post Hoc Analysis of the IRIS Trial. Journal Of The American Heart Association 2025, 14: e037663. PMID: 39921499, PMCID: PMC12074768, DOI: 10.1161/jaha.124.037663.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSilent MISilent myocardial infarctionStroke recurrenceClinical MIAssociated with stroke recurrenceFirst-ever strokeMyocardial infarctionIschemic strokeTailored prevention strategiesRecurrent strokeVascular risk factorsHistory of hospitalizationRisk of stroke recurrenceEvidence of MIUnadjusted analysisPrevention strategiesInclusion criteriaSecondary outcomesECG evidence of MIPrimary outcomeRisk factorsMultivariate Cox regression analysisPost Hoc AnalysisStrokeRegression analysis
2024
Lipid‐Lowering Therapy Use When Indicated and Subsequent Ischemic Stroke Severity
Gordon-Kundu B, Peyravi R, Garg A, Baker A, Salas S, Levien M, Faridi K, de Havenon A, Krumholz H, Sheth K, Forman R, Sharma R. Lipid‐Lowering Therapy Use When Indicated and Subsequent Ischemic Stroke Severity. Journal Of The American Heart Association 2024, 14: e033365. PMID: 39699007, PMCID: PMC12054410, DOI: 10.1161/jaha.123.033365.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsPrescribed lipid-lowering therapyNational Institutes of Health Stroke Scale scoreAcute ischemic strokeLipid-Lowering TherapyStroke Scale scoreStroke severityGuidelines-Stroke registryAtherosclerotic cardiovascular disease eventsCardiovascular disease eventsScale scoreGuideline-recommended criteriaSevere stroke symptomsStudy assessed usePropensity score subclassificationLipid-lowering therapy useNational InstituteLogistic regression modelsCholesterol management guidelinesPoststroke disabilityElevated low-density lipoprotein cholesterolInstitutional GetSmall vessel diseaseTime of acute ischemic strokeLarge-artery atherosclerosisLow-density lipoprotein cholesterolSocioeconomic and medical determinants of state‐level subjective cognitive decline in the United States
de Havenon A, Stulberg E, Littig L, Wong K, Sarpong D, Li V, Sharma R, Falcone G, Williamson J, Pajewski N, Gottesman R, Brickman A, Sheth K. Socioeconomic and medical determinants of state‐level subjective cognitive decline in the United States. Alzheimer's & Dementia 2024, 20: 7567-7579. PMID: 39351858, PMCID: PMC11567845, DOI: 10.1002/alz.14220.Peer-Reviewed Original ResearchCitationsConceptsSubjective cognitive declinePrevalence of diabetesPrevalence of povertyMedical determinantsBehavioral Risk Factor Surveillance SystemRisk Factor Surveillance SystemCognitive declinePrevalence of subjective cognitive declineBurden of cognitive declinePopulation levelState-level prevalenceMedical risk factorsFunctional impairmentState-level associationsPhysician densityUnited StatesMedical factorsRates of povertyState-level analysisHousehold incomePrimary outcomeCollege educationSurveillance systemRisk factorsEthnic minorities
Clinical Trials
Current Trials
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)
HIC ID2000031893RoleSub InvestigatorPrimary Completion Date03/07/2028Recruiting ParticipantsGenderBothAge30 years - 80 yearsAnticoagulation for Stroke Prevention and Recovery After ICH (ASPIRE)
HIC ID2000026409RoleSub InvestigatorPrimary Completion Date04/30/2028Recruiting ParticipantsGenderBothAge18+ years
Academic Achievements & Community Involvement
Copy Link
Activities
activity Stroke
2019 - PresentJournal ServiceRevieweractivity Neurology
2019 - PresentJournal ServiceRevieweractivity Circulation
2019 - PresentJournal ServiceRevieweractivity American Heart Association/American Stroke Association
2017 - PresentProfessional OrganizationsMemberactivity American Academy of Neurology
2017 - PresentProfessional OrganizationsMember
Honors
honor Selected NIH StrokeNet Educational Core Trainee Representative
10/06/2020National AwardDetailsUnited Stateshonor Record Annual Telestroke Volume, Massachusetts General Hospital
10/06/2020Other AwardDetailsUnited Stateshonor Record Annual IV-tPA Volume, Massachusetts General Hospital
06/30/2018Other AwardDetailsUnited Stateshonor Vice Dean’s Clinical Science Research Award
06/01/2012Other AwardDetailsUnited Stateshonor Eugene A. Stead Research Scholarship
05/02/2011Other AwardDetailsUnited States
Clinical Care
Copy Link
Overview
Richa Sharma, MD, MPH, is a vascular neurologist who specializes in prevention and treatment of ischemic and hemorrhagic strokes. She trained in neurology as a resident at Johns Hopkins Hospital and in vascular neurology at Massachusetts General Hospital as a fellow. Dr. Sharma was also selected as the StrokeNet Research Fellow at the Massachusetts General Hospital. Her research interests include applying novel computational techniques to identify the underlying causes of stroke in individual patients. She is also interested in cardioembolic sources of stroke.
Clinical Specialties
Stroke; Neurology
Fact Sheets
Ischemic Stroke
Learn More on Yale MedicineHemorrhagic Stroke
Learn More on Yale MedicineStroke
Learn More on Yale MedicineBlood Clots in Veins, Heart and Lungs
Learn More on Yale Medicine
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews
Copy Link
Get In Touch
Copy Link
Contacts
Appointment Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.